Professor Margie Danchin[/caption]
Dr Peter Tenni[/caption]
How should we deprescribe gabapentinoids, according to the Maudsley Deprescribing Guidelines[/caption]
PSA18 maps out the future of pharmacy
PSA18 has wrapped up in Sydney, with the future of pharmacy firmly in sight as PSA presented the Pharmacists in 2023 Discussion Paper, a...
PBS listings for cancer, Parkinson’s and motor neurone disease
Since 1 April, medicines crucial to those suffering from cancer, Parkinson’s and motor neurone disease have become available on the Pharmaceutical Benefits Scheme (PBS).
The...
How pharmacists can treat people with migraine
A look at the pharmacological and nonpharmacological treatment options and preventative measures that pharmacists can recommend to stave off migraine attacks.
A common reason people...
We must embrace change and lead new models of care
Since becoming National President, I have received significant levels of feedback in support of PSA’s development of pharmacists working in general practice.
I have also...
PSA voices support for pill testing
The Pharmaceutical Society of Australia (PSA) has announced their support for pill testing at music festivals and other environments where illicit drug use occurs,...
Decoding the lure of the bush
Recruitment is a perennial challenge for rural pharmacy. So what is being done to change this?
It will come as no surprise to many pharmacists...
